{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:46:12Z","timestamp":1791402372699,"version":"4.3.3"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s10549-024-07603-4","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T14:37:35Z","timestamp":1738420655000},"page":"645-659","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Molecular Dynamics of Breast Cancer Subtypes: The Role of FAM83H-AS1 Long Non-coding RNA in Breast Cancer Metastasis"],"prefix":"10.1007","volume":"210","author":[{"given":"Mohammad Hossein","family":"Hashemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Moaiery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahram","family":"Nikkhoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soma","family":"Mahmoodian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzieh","family":"Soheili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhila","family":"Bahramirad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MohammadBagher","family":"KhademErfan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayazid","family":"Ghaderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Erfan","family":"Keyhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherko","family":"Nasseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,1]]},"reference":[{"key":"7603_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M et al (2022) Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast 66:15\u201323","journal-title":"Breast"},{"issue":"1","key":"7603_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73(1):17\u201348","journal-title":"CA Cancer J Clin"},{"key":"7603_CR3","doi-asserted-by":"crossref","unstructured":"Kiang KM-Y, Zhang X-Q, Leung GK-K. Long non-coding RNAs: the key players in glioma pathogenesis. Cancers. 2015;7(3):1406\u201324.","DOI":"10.3390\/cancers7030843"},{"key":"7603_CR4","doi-asserted-by":"crossref","unstructured":"Shen X-h, Qi P, Du X. Long non-coding RNAs in cancer invasion and metastasis. Modern Pathology. 2015;28(1):4\u201313.","DOI":"10.1038\/modpathol.2014.75"},{"issue":"1","key":"7603_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12935-020-1148-8","volume":"20","author":"Q Yang","year":"2020","unstructured":"Yang Q, Wang J, Zhong P, Mou T, Hua H, Liu P et al (2020) The clinical prognostic value of lncRNA FAM83H-AS1 in cancer patients: a meta-analysis. Cancer Cell Int 20(1):72","journal-title":"Cancer Cell Int"},{"key":"7603_CR6","doi-asserted-by":"crossref","unstructured":"Yang F, Lv S-X, Lv L, Liu Y-H, Dong S-Y, Yao Z-H, et al. Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer. OncoTargets and therapy. 2016:7039\u201345.","DOI":"10.2147\/OTT.S110055"},{"key":"7603_CR7","doi-asserted-by":"publisher","first-page":"7039","DOI":"10.2147\/OTT.S110055","volume":"9","author":"F Yang","year":"2016","unstructured":"Yang F, Lv S-X, Lv L, Liu Y-H, Dong S-Y, Yao Z-H et al (2016) Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer. Onco Targets Ther 9:7039\u20137045","journal-title":"Onco Targets Ther"},{"issue":"4","key":"7603_CR8","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.18632\/aging.102832","volume":"12","author":"C Han","year":"2020","unstructured":"Han C, Fu Y, Zeng N, Yin J, Li Q (2020) LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p\/metadherin axis. Aging (Albany NY) 12(4):3594\u20133616","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"7603_CR9","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1038\/s41598-019-40094-8","volume":"9","author":"JA Barr","year":"2019","unstructured":"Barr JA, Hayes KE, Brownmiller T, Harold AD, Jagannathan R, Lockman PR et al (2019) Long non-coding RNA FAM83H-AS1 is regulated by human papillomavirus 16 E6 independently of p53 in cervical cancer cells. Sci Rep 9(1):3662","journal-title":"Sci Rep"},{"key":"7603_CR10","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ejphar.2019.03.002","volume":"852","author":"Q Dou","year":"2019","unstructured":"Dou Q, Xu Y, Zhu Y, Hu Y, Yan Y, Yan H (2019) LncRNA FAM83H-AS1 contributes to the radioresistance, proliferation, and metastasis in ovarian cancer through stabilizing HuR protein. Eur J Pharmacol 852:134\u2013141","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"7603_CR11","doi-asserted-by":"publisher","first-page":"4687","DOI":"10.1002\/jcb.27758","volume":"120","author":"H Shan","year":"2019","unstructured":"Shan H, Yang Y, Zhu X, Han X, Zhang P, Zhang X (2019) FAM83H-AS1 is associated with clinical progression and modulates cell proliferation, migration, and invasion in bladder cancer. J Cell Biochem 120(3):4687\u20134693","journal-title":"J Cell Biochem"},{"issue":"11","key":"7603_CR12","doi-asserted-by":"publisher","first-page":"8896","DOI":"10.1002\/jcp.26813","volume":"233","author":"Y-Y Bi","year":"2018","unstructured":"Bi Y-Y, Shen G, Quan Y, Jiang W, Xu F (2018) Long noncoding RNA FAM83H-AS1 exerts an oncogenic role in glioma through epigenetically silencing CDKN1A (p21). J Cell Physiol 233(11):8896\u20138907","journal-title":"J Cell Physiol"},{"issue":"3","key":"7603_CR13","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1159\/000493286","volume":"49","author":"N Song","year":"2018","unstructured":"Song N, Zhong J, Hu Q, Gu T, Yang B, Zhang J et al (2018) FGF18 enhances migration and the epithelial-mesenchymal transition in breast cancer by regulating Akt\/GSK3\u03b2\/\u0392-Catenin signaling. Cell Physiol Biochem 49(3):1060\u20131073","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"7603_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4103\/IJPM.IJPM_924_19","volume":"64","author":"MS Farrag","year":"2021","unstructured":"Farrag MS, Anter AH, Farrag NS, Ibrahiem AT (2021) Switch of E-Cadherin to N-Cadherin expression in different molecular subtypes of breast invasive duct carcinomas and its correlation with clinicopathological features. Indian J Pathol Microbiol 64(1):38\u201346","journal-title":"Indian J Pathol Microbiol"},{"issue":"5","key":"7603_CR15","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4297\/najms.2011.3227","volume":"3","author":"R Singhai","year":"2011","unstructured":"Singhai R, Patil VW, Jaiswal SR, Patil SD, Tayade MB, Patil AV (2011) E-Cadherin as a diagnostic biomarker in breast cancer. N Am J Med Sci 3(5):227\u2013233","journal-title":"N Am J Med Sci"},{"issue":"7","key":"7603_CR16","first-page":"1696","volume":"53","author":"H Oka","year":"1993","unstructured":"Oka H, Shiozaki H, Kobayashi K, Inoue M, Tahara H, Kobayashi T et al (1993) Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 53(7):1696\u20131701","journal-title":"Cancer Res"},{"issue":"4","key":"7603_CR17","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/ajcp\/105.4.394","volume":"105","author":"SM Siitonen","year":"1996","unstructured":"Siitonen SM, Kononen JT, Helin HJ, Rantala IS, Holli KA, Isola JJ (1996) Reduced E-Cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am J Clin Pathol 105(4):394\u2013402","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"7603_CR18","doi-asserted-by":"publisher","first-page":"7693","DOI":"10.1007\/s13277-014-1975-0","volume":"35","author":"S Li","year":"2014","unstructured":"Li S, Li S, Sun Y, Li L (2014) The expression of \u03b2-catenin in different subtypes of breast cancer and its clinical significance. Tumor Biology 35(8):7693\u20137698","journal-title":"Tumor Biology"},{"issue":"2","key":"7603_CR19","doi-asserted-by":"publisher","first-page":"R296","DOI":"10.1186\/bcr983","volume":"7","author":"A-M T\u0151k\u00e9s","year":"2005","unstructured":"T\u0151k\u00e9s A-M, Kulka J, Paku S, Szik \u00c1, P\u00e1ska C, Nov\u00e1k PK et al (2005) Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res 7(2):R296","journal-title":"Breast Cancer Res"},{"issue":"9","key":"7603_CR20","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1093\/annonc\/mdn180","volume":"19","author":"P McGowan","year":"2008","unstructured":"McGowan P, Duffy M (2008) Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database. Ann Oncol 19(9):1566\u20131572","journal-title":"Ann Oncol"},{"issue":"5","key":"7603_CR21","first-page":"5865","volume":"14","author":"H Li","year":"2017","unstructured":"Li H, Qiu Z, Li F, Wang C (2017) The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis. Oncol Lett 14(5):5865\u20135870","journal-title":"Oncol Lett"},{"issue":"1","key":"7603_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4103\/nmj.NMJ_7_19","volume":"60","author":"C Khillare","year":"2019","unstructured":"Khillare C, Sinai Khandeparkar S, Joshi A, Kulkarni M, Gogate B, Battin S (2019) Immunohistochemical expression of vimentin in invasive breast carcinoma and its correlation with clinicopathological parameters. Niger Med J 60(1):17\u201321","journal-title":"Niger Med J"},{"issue":"4","key":"7603_CR23","doi-asserted-by":"publisher","first-page":"287","DOI":"10.21608\/mjmr.2022.218143","volume":"31","author":"MA Mohamed","year":"2020","unstructured":"Mohamed MA, Teleb SG, Abd El-Rehim DM, Abd-Elghany MI, Gayyed MF (2020) High Snail 1 expression is a poor prognostic factor in patients with invasive ductal carcinoma of the breast. Minia J Med Res 31(4):287\u2013295","journal-title":"Minia J Med Res"},{"issue":"3","key":"7603_CR24","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10549-015-3485-1","volume":"152","author":"SY Cheung","year":"2015","unstructured":"Cheung SY, Boey YJY, Koh VCY, Thike AA, Lim JCT, Iqbal J et al (2015) Role of epithelial\u2013mesenchymal transition markers in triple-negative breast cancer. Breast Cancer Res Treat 152(3):489\u2013498","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"7603_CR25","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a003277","volume":"3","author":"H Moses","year":"2011","unstructured":"Moses H, Barcellos-Hoff MH (2011) TGF-\u03b2 biology in mammary development and breast cancer. Cold Spring Harb Perspect Biol 3(1):a003277","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"6","key":"7603_CR26","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1172\/JCI39675","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R (2009) EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest 119(6):1417\u20131419","journal-title":"J Clin Invest"},{"issue":"4","key":"7603_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.5487\/TR.2010.26.4.245","volume":"26","author":"H Son","year":"2010","unstructured":"Son H, Moon A (2010) Epithelial-mesenchymal transition and cell invasion. Toxicol Res 26(4):245\u2013252","journal-title":"Toxicol Res"},{"issue":"2","key":"7603_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10911-010-9178-9","volume":"15","author":"DS Micalizzi","year":"2010","unstructured":"Micalizzi DS, Farabaugh SM, Ford HL (2010) Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 15(2):117\u2013134","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"2","key":"7603_CR29","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s10549-020-05627-0","volume":"181","author":"CLT J\u00f8rgensen","year":"2020","unstructured":"J\u00f8rgensen CLT, Forsare C, Bendahl PO, Falck AK, Fern\u00f6 M, L\u00f6vgren K et al (2020) Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression. Breast Cancer Res Treat 181(2):369\u2013381","journal-title":"Breast Cancer Res Treat"},{"key":"7603_CR30","doi-asserted-by":"crossref","unstructured":"Loh CY, Chai JY, Tang TF, Wong WF, Sethi G, Shanmugam MK, et al. The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges. Cells. 2019;8(10).","DOI":"10.3390\/cells8101118"},{"issue":"18","key":"7603_CR31","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1007\/s00018-011-0735-1","volume":"68","author":"A Satelli","year":"2011","unstructured":"Satelli A, Li S (2011) Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci 68(18):3033\u20133046","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"7603_CR32","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1093\/carcin\/bgu041","volume":"35","author":"AK Reka","year":"2014","unstructured":"Reka AK, Chen G, Jones RC, Amunugama R, Kim S, Karnovsky A et al (2014) Epithelial-mesenchymal transition-associated secretory phenotype predicts survival in lung cancer patients. Carcinogenesis 35(6):1292\u20131300","journal-title":"Carcinogenesis"},{"issue":"9","key":"7603_CR33","doi-asserted-by":"publisher","first-page":"603","DOI":"10.5732\/cjc.011.10226","volume":"30","author":"Y Wang","year":"2011","unstructured":"Wang Y, Zhou BP (2011) Epithelial-mesenchymal transition in breast cancer progression and metastasis. Chin J Cancer 30(9):603\u2013611","journal-title":"Chin J Cancer"},{"key":"7603_CR34","doi-asserted-by":"publisher","first-page":"1164301","DOI":"10.3389\/fcell.2023.1164301","volume":"11","author":"SK Baba","year":"2023","unstructured":"Baba SK, Baba SK, Mir R, Elfaki I, Algehainy N, Ullah MF et al (2023) Long non-coding RNAs modulate tumor microenvironment to promote metastasis: novel avenue for therapeutic intervention. Front Cell Develop Biol 11:1164301","journal-title":"Front Cell Develop Biol"},{"key":"7603_CR35","unstructured":"Rafat M, Afsa M, Nikbakht M, Malekzadeh K. Spotlight on the expanding role of DANCR in tumorigenesis and tumor progression. 2023."},{"issue":"1","key":"7603_CR36","first-page":"15","volume":"1","author":"AD Mancheng","year":"2022","unstructured":"Mancheng AD, Ossas U (2022) How does Lncrna regulation impact cancer metastasis. Cancer Insight 1(1):15\u201334","journal-title":"Cancer Insight"},{"issue":"1","key":"7603_CR37","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s13046-022-02491-2","volume":"41","author":"M Zhou","year":"2022","unstructured":"Zhou M, Pan S, Qin T, Zhao C, Yin T, Gao Y et al (2022) LncRNA FAM83H-AS1 promotes the malignant progression of pancreatic ductal adenocarcinoma by stabilizing FAM83H mRNA to protect \u03b2-catenin from degradation. J Exp Clin Cancer Res 41(1):288","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"7603_CR38","doi-asserted-by":"publisher","first-page":"316","DOI":"10.2174\/1574892818666230427164227","volume":"19","author":"X Jiang","year":"2024","unstructured":"Jiang X, Lan Y, Zhang Y, Dong Y, Song T (2024) LncRNA FAM83H-AS1 contributes to the radio-resistance and proliferation in Liver Cancer through Stability FAM83H Protein. Recent Pat Anti-Cancer Drug Discovery 19(3):316\u2013327","journal-title":"Recent Pat Anti-Cancer Drug Discovery"},{"key":"7603_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118193","volume":"259","author":"NE El-Ashmawy","year":"2020","unstructured":"El-Ashmawy NE, Hussien FZ, El-Feky OA, Hamouda SM, Al-Ashmawy GM (2020) Serum LncRNA-ATB and FAM83H-AS1 as diagnostic\/prognostic non-invasive biomarkers for breast cancer. Life Sci 259:118193","journal-title":"Life Sci"},{"issue":"3","key":"7603_CR40","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/cbf.3601","volume":"39","author":"NE El-Ashmawy","year":"2021","unstructured":"El-Ashmawy NE, Al-Ashmawy GM, Hamouda SM (2021) Long non-coding RNA FAM83H-AS1 as an emerging marker for diagnosis, prognosis and therapeutic targeting of cancer. Cell Biochem Funct 39(3):350\u2013356","journal-title":"Cell Biochem Funct"},{"issue":"16","key":"7603_CR41","doi-asserted-by":"publisher","first-page":"8962","DOI":"10.1111\/jcmm.15530","volume":"24","author":"B Feng","year":"2020","unstructured":"Feng B, Wang G, Liang X, Wu Z, Wang X, Dong Z et al (2020) LncRNA FAM83H-AS1 promotes oesophageal squamous cell carcinoma progression via miR-10a-5p\/Girdin axis. J Cell Mol Med 24(16):8962\u20138976","journal-title":"J Cell Mol Med"},{"issue":"1","key":"7603_CR42","doi-asserted-by":"publisher","first-page":"14145","DOI":"10.1038\/s41598-020-71062-2","volume":"10","author":"M R\u00edos-Romero","year":"2020","unstructured":"R\u00edos-Romero M, Cedro-Tanda A, Pe\u00f1a-Luna M, Mancera-Rodr\u00edguez MA, Hidalgo-P\u00e9rez L, Cisneros-Villanueva M et al (2020) FAM83H-AS1 is a potential modulator of cancer driver genes across different tumors and a prognostic marker for ER\/PR + BRCA patients. Sci Rep 10(1):14145","journal-title":"Sci Rep"},{"issue":"1","key":"7603_CR43","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s13046-022-02491-2","volume":"41","author":"M Zhou","year":"2022","unstructured":"Zhou M, Pan S, Qin T, Zhao C, Yin T, Gao Y et al (2022) LncRNA FAM83H-AS1 promotes the malignant progression of pancreatic ductal adenocarcinoma by stabilizing FAM83H mRNA to protect \u03b2-catenin from degradation. J Exp Clin Cancer Res CR 41(1):288","journal-title":"J Exp Clin Cancer Res CR"},{"key":"7603_CR44","unstructured":"Gong Y-B, Zou Y-F. Clinical significance of lncRNA FAM83H-AS1 in ovarian cancer. European Review for Medical & Pharmacological Sciences. 2019;23(11)."},{"issue":"6","key":"7603_CR45","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.ctrv.2011.11.001","volume":"38","author":"C Foroni","year":"2012","unstructured":"Foroni C, Broggini M, Generali D, Damia G (2012) Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact. Cancer Treat Rev 38(6):689\u2013697","journal-title":"Cancer Treat Rev"},{"key":"7603_CR46","doi-asserted-by":"crossref","unstructured":"Wu Y, Sarkissyan M, Vadgama JV. Epithelial-Mesenchymal Transition and Breast Cancer. J Clin Med. 2016;5(2).","DOI":"10.3390\/jcm5020013"},{"issue":"6","key":"7603_CR47","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M et al (2020) Guidelines and definitions for research on epithelial\u2013mesenchymal transition. Nat Rev Mol Cell Biol 21(6):341\u2013352","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"7603_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2023.13857","volume":"25","author":"W Wang","year":"2023","unstructured":"Wang W, Jin J, Zhou Z, Wang Y, Min K, Zuo X et al (2023) Snail inhibits metastasis via regulation of E-cadherin and is associated with prognosis in colorectal cancer. Oncol Lett 25(6):1\u201310","journal-title":"Oncol Lett"},{"issue":"1","key":"7603_CR49","first-page":"S30","volume":"12","author":"S Mohammadpour","year":"2019","unstructured":"Mohammadpour S, Esfahani AT, Karimpour R, Bakhshian F, Tabatabaei SAM, Laleh A et al (2019) High expression of Snail1 is associated with EMAST and poor prognosis in CRC patients. Gastroenterol Hepatol from bed to bench 12(1):S30","journal-title":"Gastroenterol Hepatol from bed to bench"},{"issue":"19","key":"7603_CR50","doi-asserted-by":"publisher","first-page":"8903","DOI":"10.7150\/thno.45785","volume":"10","author":"J-E Wu","year":"2020","unstructured":"Wu J-E, Wu Y-Y, Tung C-H, Tsai Y-T, Chen H-Y, Chen Y-L et al (2020) DNA methylation maintains the CLDN1-EPHB6-SLUG axis to enhance chemotherapeutic efficacy and inhibit lung cancer progression. Theranostics 10(19):8903","journal-title":"Theranostics"},{"issue":"22","key":"7603_CR51","doi-asserted-by":"publisher","first-page":"7621","DOI":"10.1158\/1078-0432.CCR-04-1061","volume":"10","author":"JM Pellikainen","year":"2004","unstructured":"Pellikainen JM, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma V-M (2004) Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator Protein-2, HER2, and Prognosis. Clin Cancer Res 10(22):7621\u20137628","journal-title":"Clin Cancer Res"},{"issue":"6","key":"7603_CR52","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1002\/jcb.24087","volume":"113","author":"AM Scherbakov","year":"2012","unstructured":"Scherbakov AM, Andreeva OE, Shatskaya VA, Krasil\u2019nikov MA (2012) The relationships between snail1 and estrogen receptor signaling in breast cancer cells. J Cell Biochem 113(6):2147\u20132155","journal-title":"J Cell Biochem"},{"key":"7603_CR53","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00432-013-1376-6","volume":"139","author":"N Yamashita","year":"2013","unstructured":"Yamashita N, Tokunaga E, Kitao H, Hisamatsu Y, Taketani K, Akiyoshi S et al (2013) Vimentin as a poor prognostic factor for triple-negative breast cancer. J Cancer Res Clin Oncol 139:739\u2013746","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"7603_CR54","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4103\/ejh.ejh_9_22","volume":"48","author":"MGN Meleak","year":"2023","unstructured":"Meleak MGN, El-Metwally RA, Azzazi MO, Moussa MM, El-Ghammaz AM, Mohamed HS (2023) Prognostic value of serum vimentin in adult Egyptian patients with acute lymphoblastic leukemia. Egypt J Haematol 48(2):95\u2013102","journal-title":"Egypt J Haematol"},{"key":"7603_CR55","doi-asserted-by":"crossref","unstructured":"Hu R, Yu Y, Qin H, Yan B, Yu J, Wen Z. Vimentin overexpression correlates with clinicopathologic features and poor prognosis of esophagus cancer patients: a systematic review and meta-analysis. 2023.","DOI":"10.21203\/rs.3.rs-2982029\/v1"},{"issue":"1","key":"7603_CR56","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.bbrc.2018.05.139","volume":"502","author":"X Xu","year":"2018","unstructured":"Xu X, Zhang L, He X, Zhang P, Sun C, Xu X et al (2018) TGF-\u03b2 plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT, and apoptosis. Biochem Biophys Res Commun 502(1):160\u2013165","journal-title":"Biochem Biophys Res Commun"},{"key":"7603_CR57","doi-asserted-by":"crossref","unstructured":"Zhang H, Wang J, Yin Y, Meng Q, Lyu Y. The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis. Biosci Rep. 2021;41(2).","DOI":"10.1042\/BSR20203121"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07603-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-024-07603-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07603-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T23:35:13Z","timestamp":1743550513000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-024-07603-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,1]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["7603"],"URL":"https:\/\/doi.org\/10.1007\/s10549-024-07603-4","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,1]]},"assertion":[{"value":"23 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}